JOCS

The aim of the Comprehensive Surgery is to publish original research articles of the highest scientific and clinical value at the international level in all surgical fields. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Index
Original Article
Comparison of resected lymph nodes and additional factors in colorectal cancer patients undergoing emergency versus elective surgery
Aims: Controversy persists regarding the number of lymph nodes (LNs) that should be removed during surgery for accurate colorectal carcinoma (CRC) staging and its impact on prognosis. The effects of other prognostic factors on survival, such as the metastatic LN to resected LN (LNR) ratio and the type of surgical approach, were retrospectively examined.
Methods: A total of 325 patients who underwent emergency or elective surgery for CRC between March 1st, 2019, and December 31st, 2022, were included in the study. Age, sex, tumor location, stage, number of resected LNs, number of metastatic LNs, presence of distant metastases, distance of the tumor from the surgical margins, need for ostomy opening, development of postoperative complications, and level of tumor markers at diagnosis were recorded for patient records.
Results: The data of 142 (43.7%) emergency surgery patients and 183 (56.3%) elective surgery patients were compared. It was revealed that there was a positive relationship between the removal of at least 22 LNs during surgery and survival (p = 0.036). Factors such as age, a high LNR, emergency surgery, advanced stage of CRC, and not receiving adjuvant chemotherapy were significant predictors of increased mortality (age: hazard ratio (HR): 1.03, 95% CI: 1.01–1.05, p < 0.001; LNR: HR: 4.74, 95% CI: 1.69–13.3, p = 0.003; emergency surgery: HR: 2.33, 95% CI: 1.51–3.59, p < 0.001; advanced stage: HR: 3.24, 95% CI: 1.81–5.79, p < 0.001; adjuvant chemotherapy: HR: 4.93, 95% CI: 2.94–8.25, p < 0.001) in the patients with CRC.
Conclusion: Patients with CRC, who had fewer LN dissections, perforation-related peritonitis, advanced disease, were not receiving adjuvant chemotherapy, and emergency surgery, had a worse prognosis.


1. Fingerhut A. What counts most in the lymph node count for colorectal cancer?. <em>Surg Innov.</em> 2012;19(3):213-215.
2. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. <em>Ann Surg Oncol.</em> 2010;17(6):1471-1474.
3. Song YX, Gao P, Wang ZN, et al. Which is the most suitable classification for colorectal cancer, log odds, the number, or the ratio of positive lymph nodes?. <em>PLoS One.</em> 2011;6(12):e28937.
4. Scabini S. Sentinel node biopsy in colorectal cancer: must we believe it?. <em>World J Gastrointest Surg.</em> 2010;2(1):6-8.
5. Leung AM, Scharf AW, Vu HN. Factors affecting number of lymph nodes harvested in colorectal cancer. <em>J Surg Res.</em> 2011;168(2):224-230.
6. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. <em>J Natl Cancer Inst.</em> 2007;99(6):433-441.
7. Noura S, Ohue M, Kano S, et al. Impact of metastatic lymph node ratio in node-positive colorectal cancer. <em>World J Gastrointest Surg.</em> 2010;2(3): 70-77.
8. McDonald JR, Renehan AG, O&rsquo;Dwyer ST, Haboubi NY. Lymph node harvest in colon and rectal cancer: current considerations. <em>World J Gastrointest Surg.</em> 2012;4(1):9-19.
9. Betge J, Harbaum L, Pollheimer MJ, et al. Lymph node retrieval in colorectal cancer: determining factors and prognostic significance. <em>Int J Colorectal Dis.</em> 2017;32(7):991-998.
10. Chen YJ, Yeh ST, Kao PS, Ou LH, Lin CS. A reappraisal of lymph node dissection in colorectal cancer during primary surgical resection. <em>World J Surg Oncol.</em> 2020;18(1):97.
11. Qiao Y, Zhu J, Han T, et al. Finding the minimum number of retrieved lymph nodes in node-negative colorectal cancer using real-world data and the SEER database. <em>Int J Surg.</em> 2023;109(12):4173-4184.
12. Kuo YH, Lee KF, Chin CC, Huang WS, Yeh CH, Wang JY. Does body mass index impact the number of LNs harvested and influence long-term survival rate in patients with stage III colon cancer?. <em>Int J Colorectal Dis.</em> 2012;27(12):1625-1635.
13. Wong SL. Lymph node counts and survival rates after resection for colon and rectal cancer. <em>Gastrointest Cancer Res.</em> 2009;3(2 Suppl): S33-S35.
14. Orsenigo E, Gasparini G, Carlucci M. Clinicopathological factors influencing lymph node yield in colorectal cancer: a retrospective study. <em>Gastroenterol Res Pract.</em> 2019;2019:5197914.
15. Nelson H, Petrelli N, Carlin A, et a. National cancer institute expert panel. Guidelines 2000 for colon and rectal cancer surgery. <em>J Natl Cancer Inst.</em> 2001;93(8):583-96.
16. Feng H, Lyu Z, Liang W, et al. Optimal examined lymph node count in node-negative colon cancer should be determined. <em>Future Oncol.</em> 2021; 17(29):3865-3872.
17. Wu W, Li D, Ma W, et al. Examining more lymph nodes may improve the prognosis of patients with right colon cancer: determining the optimal minimum lymph node count. <em>Cancer Control.</em> 2021;28: 10732748211064034.
18. Lee L, Erkan A, Alhassan N, et al. Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?. <em>Surg Oncol.</em> 2018;27(3):449-455.
19. Hayes IP, Milanzi E, Gibbs P, Faragher I, Reece JC. Is increasing nodal count associated with improved recurrence-free and overall survival following standard right hemicolectomy for colon cancer?. <em>J Surg Oncol.</em> 2022;126(3):523-534.
20. de Lacy FB, Chadi SA, Berho M, et al. The future of rectal cancer surgery: a narrative review of an International Symposium. <em>Surg Innov.</em> 2018;25(5):525-535.
21. Benz SR, Feder IS, Vollmer S, et al. Complete mesocolic excision for right colonic cancer: prospective multicentre study. <em>Br J Surg.</em> 2022; 110(1):98-105.
22. Li Destri G, Di Carlo I, Scilletta R, Scilletta B, Puleo S. Colorectal cancer and lymph nodes: the obsession with the number 12. <em>World J Gastroenterol.</em> 2014;20(8):1951-1960.
23. Biondo S, G&aacute;lvez A, Ram&iacute;rez E, Frago R, Kreisler E. Emergency surgery for obstructing and perforated colon cancer: patterns of recurrence and prognostic factors. <em>Tech Coloproctol.</em> 2019:1141-1161.
24. Chen TM, Huang YT, Wang GC. Outcome of colon cancer initially presenting as colon perforation and obstruction. <em>World J Surg Oncol.</em> 2017;15(1):164.
25. Asano H, Fukano H, Takagi M, Takayama T. Risk factors for the recurrence of stage II perforated colorectal cancer: a retrospective observational study. <em>Asian J Surg.</em> 2023;46(1):201-206.
26. Pisano M, Zorcolo L, Merli C, et al. 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation. <em>World J Emerg Surg.</em> 2018;13:36.
27. Yang KM, Jeong MJ, Yoon KH, Jung YT, Kwak JY. Oncologic outcome of colon cancer with perforation and obstruction. <em>BMC Gastroenterol.</em> 2022;22(1):247.
28. Ha GS, Kim YW, Choi EH, Kim IY. Factors associated with the lack of adjuvant chemotherapy following curative surgery for stage ii and iii colon cancer: a Korean national cohort study. <em>Anticancer Res.</em> 2017; 37(2):915-922.
29. Kim CH, Bae JH, Lee CS, et al. Which prognostic factors are important for long-term outcomes in symptomatic obstructive colon cancer? A multi-institutional retrospective cohort study. <em>J Minim Invasive Surg.</em> 2021;24(3):128-138.
30. Kim CH, Bae JH, Lee CS, et al. Which prognostic factors are important for long-term outcomes in symptomatic obstructive colon cancer? A multi-institutional retrospective cohort study. <em>J Minim Invasive Surg.</em> 2021;24(3):128-138.
31. Ha GS, Kim YW, Choi EH, Kim IY. Factors associated with the lack of adjuvant chemotherapy following curative surgery for stage ii and iii colon cancer: a Korean National cohort study. <em>Anticancer Res.</em> 2017; 37(2):915-922.
32. Bj&ouml;rkman K, Mustonen H, Kaprio T, et al. CA125: a superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242. <em>Tumour Biol.</em> 2021;43(1):57-70.
33. Holt J, Schwalb H, Elbourne H, Te Marvelde L, Reid C. Risk factors for recurrence in colorectal cancer: a retrospective analysis in a regional Australian hospital. <em>ANZ J Surg.</em> 2021;91(11):2482-2486.
34. Aguiar Junior S, Oliveira MM, Silva DRME, Mello CAL, Calsavara VF, Curado MP. Survival of patients with colorectal cancer in a cancer center. <em>Arq Gastroenterol.</em> 2020;57(2):172-177.
35. Mislang AR, Di Donato S, Hubbard J, et al. Nutritional management of older adults with gastrointestinal cancers: an International Society of Geriatric Oncology (SIOG) review paper. <em>J Geriatr Oncol.</em> 2018;9(4):382-392.
36. Yamano T, Yamauchi S, Kimura K, et al. Japanese study group for postoperative follow-up of colorectal cancer. Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: a retrospective multicentre study. <em>Eur J Cancer.</em> 2017;81:90-101.
Volume 2, Issue 4, 2024
Page : 86-92
_Footer